15th Apr 2008 14:40
Hikma Pharmaceuticals Plc15 April 2008 Notice of Annual Report and Accounts LONDON, 15 April 2008 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX:HIK), the multinational pharmaceuticals group, announces that the Company'sAnnual Report and Accounts for the year ending 31 December 2007 has been postedto shareholders. A copy of the report can be found on the Company's website (www.hikma.com) and on the DIFX website (www.difx.ae). - ENDS - Enquiries: Hikma Pharmaceuticals PLCSusan Ringdal +44 20 7399 2760Investor Relations Director Brunswick GroupJon Coles / Justine McIlroy / +44 20 7404 5959Alex Tweed About Hikma Hikma Pharmaceuticals PLC is a fast growing multinational group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: "Branded", "Injectables" and "Generics".Hikma's operations are based principally in the Middle East and North Africa("MENA") region, where it is a market leader and sells across 17 countries, theUnited States and Europe. In 2007, the Group achieved revenues of $449 million(2006 $317 million) and profit attributable to shareholders was $63 million(2006 $55 million). For news and other information, please visit www.hikma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hikma Pharmaceuticals